Biopharmaceutical leader in the development of treatments for rare diseases
Education about the value of innovative new medicines and the Orphan Drug Act.

H.R.3: Spending Cuts to Expired and Unnecessary Programs Act as it relates to CHIP funding.

Right to Try legislation. Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.

Medicare home Infusion benefit under Part B.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX